UPPSALA, SE / ACCESSWIRE / December 2, 2024 / Biovica Worldwide (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, energetic within the monitoring of blood most cancers, proclaims right this moment that the corporate has signed a business settlement (buyer bill) with one of many largest medical health insurance corporations within the USA, with revenues exceeding 100 billion of . The corporate is each a medical health insurance and healthcare providers supplier serving greater than 10 million Individuals by way of its insurance coverage insurance policies.
“It is a main breakthrough for Biovica made by our US staff. The group has been utilizing DiviTum TKa and sees affected person advantages in addition to well being financial advantages with the check, which paved the best way for this settlement. If the Continued use is essentially the most If profitable, DiviTum TKa is predicted to turn out to be the usual of care throughout this vital group. Partnerships like this are essential to driving sustainable income development and attaining Biovica's objective of getting a pipeline. optimistic money and provide DiviTum TKa to most cancers sufferers world wide,” stated Anders Rylander, CEO of Biovica.
Contact
Anders Rylander, CEO
Phone: +46 76 666 16 47
E mail: anders.rylander@biovica.com
Anders Morén, monetary director
Phone: +46 73 125 92 46
E mail: anders.moren@biovica.com
Biovica – Remedy choices with better confidence
Biovica develops and markets blood biomarker assays that assist oncologists monitor most cancers development. Biovica's assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker within the bloodstream. The assay has demonstrated its skill to offer data on the effectiveness of the remedy in a number of scientific trials. The primary utility of the DiviTum® TKa check is to observe the therapy of sufferers with metastatic breast most cancers. Biovica's imaginative and prescient is: “Higher take care of most cancers sufferers.” Biovica collaborates with most cancers institutes and main pharmaceutical corporations on the earth. DiviTum® TKa has obtained 510(ok) clearance from the FDA within the US and is CE marked within the EU. Biovica shares are listed on the Nasdaq First North Premier Development Market (BIOVIC B). FNCA Sweden AB is the corporate's licensed advisor. For extra data, go to: www.biovica.com
Attachments
Biovica indicators settlement with American healthcare large
FOUNTAIN: Biovica Worldwide
View the unique press launch on accesswire.com